Benefit of a pharmacist-led intervention for medication management of renal transplant patients: a controlled before-and-after study

di Chambord, Jeremy, Couzi, Lionel, Merville, Pierre, Moreau, Karine, Xuereb, Fabien, Djabarouti, Sarah
Pubblicato in Ther Adv Chronic Dis (2021)

Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?

di Ollivier, Julien, Carrié, Cédric, d’Houdain, Nicolas, Djabarouti, Sarah, Petit, Laurent, Xuereb, Fabien, Legeron, Rachel, Biais, Matthieu, Breilh, Dominique
Pubblicato in Antimicrob Agents Chemother (2019)

Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

di Djabarouti, Sarah, Breilh, Dominique, Duffau, Pierre, Lazaro, Estibaliz, Greib, Carine, Caubet, Olivier, Saux, Marie-Claude, Pellegrin, Jean-Luc, Viallard, Jean-François
Pubblicazione 2010

Correction: Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

di Djabarouti, Sarah, Breilh, Dominique, Duffau, Pierre, Lazaro, Estibaliz, Greib, Carine, Caubet, Olivier, Saux, Marie-Claude, Pellegrin, Jean-Luc, Viallard, Jean-François
Pubblicazione 2011

Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases

di Streicher, Caroline, Djabarouti, Sarah, Xuereb, Fabien, Lazaro, Estibaliz, Legeron, Rachel, Bouchet, Stéphane, Greib, Carine, Breilh, Dominique, Pellegrin, Jean-Luc, Viallard, Jean-François
Pubblicato in Br J Clin Pharmacol (2014)